Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FQ1VP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,337
Award facts
- Contract value 100% obligated
- $19,336.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 19,336.98 for the supply of Dupixent 300 mg/2 ml pen auto-injectors on July 18, 2025, with an ultimate completion date of July 21, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was awarded through open competition. The performance location is listed as Conshohocken, Pennsylvania, which is AmerisourceBergen's corporate headquarters location. Dupixent is a biologic medication indicated for multiple conditions including atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis with nasal polyps, making it a specialized pharmaceutical product critical for military healthcare systems.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and running through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen has demonstrated significant capability in fulfilling complex medical procurement requirements across multiple therapeutic domains for the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQ1VP?
SPE2DB25FQ1VP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FQ1VP worth?
The government has obligated $19,337 on SPE2DB25FQ1VP.
Is contract SPE2DB25FQ1VP an order under another contract?
Yes. SPE2DB25FQ1VP is a delivery order under SPE2DB22D3011, an indefinite delivery contract.
Was contract SPE2DB25FQ1VP competed?
The extent of competition for SPE2DB25FQ1VP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award